Cardiology

COVID-19 could threaten patients' hearts

It has been months since the coronavirus pandemic gripped the nation, leaving more than 200,000 people dead—a number that continues to climb. Meanwhile, we are learning more about the virus and its unusual presentation, ...

Cardiology

Ischemic heart disease is major health burden worldwide

(HealthDay)—A total of 126.5 million people lived with ischemic heart disease (IHD) globally in 2017, with 10.6 million new cases occurring, according to a study published online Oct. 5 in the European Heart Journal: Quality ...

Medications

Results from the VOYAGER PAD Trial reported

A large subgroup analysis of a randomized clinical trial showed neither a mortality risk nor benefit associated with the use of paclitaxel drug-coated devices (DCD) in the treatment of peripheral artery disease (PAD). The ...

Cardiology

Results from the OPTIMIZE trial reported

The OPTIMIZE randomized trial comparing a novel, low-profile drug-eluting stent (DES) facilitating transradial access (TR) and direct stenting (DS) to existing DES did not establish non-inferiority of the new stent based ...

Cardiology

Results from the COBRA-REDUCE trial reported

For patients undergoing percutaneous coronary intervention (PCI) that also require oral anticoagulation, treatment with a nanotechnology polymer-coated stent plus 14-day dual anti-platelet therapy (DAPT) did not reduce bleeding ...

Cardiology

Results from host-reduce-polytech-ACS trial reported

A randomized clinical trial found that drug-eluting stents (DES) with durable polymers are non-inferior to DES with biodegradable polymers in patients with acute coronary syndrome (ACS).